Skip to Content

Glatopa Approval History

FDA Approved: Yes (First approved April 16, 2015)
Brand name: Glatopa
Generic name: glatiramer acetate
Dosage form: Injection
Company: Sandoz Inc.
Treatment for: Multiple Sclerosis

Glatopa (glatiramer acetate) is a generic version of Copaxone, an immunomodulator drug for the treatment of patients with relapsing-forms of multiple sclerosis.

Development History and FDA Approval Process for Glatopa

DateArticle
Apr 16, 2015Approval FDA Approves Glatopa (glatiramer acetate) as the First Generic Competitor to Copaxone

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide